Clik here to view.
Social media guidelines for our clinicians
We recently published this guideline at BIDMC based on the input from a multi-disciplinary working group. I thought it might be useful to share with the community, since many healthcare organizations...
View ArticleClik here to view.
Federal watchdog to investigate CMS drug rebate program
The Office of the Inspector General of the Health and Human Services Departments said last week that it will begin investigating whether the Centers for Medicare & Medicaid Services properly...
View ArticleClik here to view.
Bayer, Versant close $225m Series A to launch stem cell company
Bayer (ETR:BAYN) and Versant Ventures said today that the 2 groups closed a $225 million Series A financing round to launch BlueRock Therapeutics, a regenerative medicine company focused on developing...
View ArticleClik here to view.
Flexion seeks FDA nod for osteoarthritis steroid injection
Flexion Therapeutics (NSDQ:FLXN) said today that it submitted a new drug application to the FDA for its extended-release steroid injection Zilretta. The Burlington, Mass.-based company won Fast Track...
View ArticleClik here to view.
Philips to offload 80% stake in Lumileds for $1.5B
Royal Philips (NYSE:PHG) said today it inked an agreement to sell an 80.1% interest in its Lumileds lighting business to funds managed by Apollo Global Management affiliates, bringing in approximately...
View ArticleClik here to view.
Four major medical associations collab to form Xcertia mobile health app...
Four major medical associations said today they will group to form Xcertia, a multi-stakeholder collaboration focused on improving mobile health applications. The American Medical Association, American...
View ArticleClik here to view.
Adherium’s smart inhaler tech chosen for EU mobile health program
Adherium Ltd. (ASK:ADR) said today that its Smartinhaler was chosen for the myAirCoach program as a part of the European Union’s Horizon 2020 Framework for Research and Innovation. The Horizon 2020...
View ArticleClik here to view.
Glaukos touts IOP reduction in pseudophakic iStent study
Glaukos (NYSE:GKOS) today released data from a study of its iStent trabecular micro-bypass stent, touting reduced intraocular pressure when implanted in pseudophakic eyes with open-angle glaucoma. Data...
View ArticleClik here to view.
Phillips-Medisize to build drug delivery manufacturing facility in Wisconsin
Phillips-Medisize said today that it plans to open an 80,000 square foot drug delivery manufacturing facility at its Menomonie, Wisconsin campus. The facility, which is expected to open in 2017, will...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Pediapharm wins Health Canada nod for antibiotic, steroid combo ear drop
Pediapharm Inc. (CVE:PDP) said today that it won regulatory approval from Health Canada for its Otixal eye drop solution for the treatment of acute otitis media with tympanostomy tubes in pediatric...
View ArticleClik here to view.
Dextera launches registry study of MicroCutter 5/80 stapler
Dextera Surgical (NSDQ:DXTR) said last week it launched a registry study of its MicroCutter 5/80 surgical stapler designed for hemostasis. The Redwood City, Calif.-based company said it enrolled the...
View ArticleClik here to view.
Boston Scientific fires neurmod patent infringement suit at Nevro in ongoing...
Nevro Corp. (NYSE:NVRO) said last Friday that it received notice that Boston Scientific (NYSE:BSX) and its Neuromodulation division have filed a patent infringement suit against Nevro. The suit, filed...
View ArticleClik here to view.
Medovex sells Streamline IV suspension system assets to Skytron
Medical technology portfolio company Medovex said today it sold its Streamline IV suspension system assets to acute care focused healthcare company Skytron for an undisclosed amount. The Atlanta-based...
View ArticleClik here to view.
Defymed partners with Semma Therapeutics on bio-artificial pancreas
French biotech developer Defymed said today it inked a collaborative deal with American biotech company Semma Therapeutics to support the continued development of a bio-artificial pancreas to treat...
View ArticleClik here to view.
Toshiba Medical launches MR Theater MRI patient VR system
Toshiba Medical said today it launched the MR Theater, an immersive virtual experience designed for patients underoging magnetic resonance exams. The company said its MR Theater is designed to give...
View ArticleClik here to view.
AdvaMed launches digital health advocacy sector AdvaMed Digital
Medtech industry group AdvaMed said today it launched AdvaMed Digital, a new sector within its association dedicated to companies in the digital health space. The newly launched sector will look to...
View ArticleClik here to view.
Brazilian ANVISA issues clinical data requirements for novel medical devices
By Stewart Eisenhart, Emergo Group Brazil’s medical device market regulator ANVISA now requires clinical data for all novel medical device registrations as well as for some high-risk devices for which...
View ArticleClik here to view.
SMC Ltd. Expands Drug Delivery Capabilities with Oval Medical Technologies...
SMC Ltd., a global contract manufacturer of pharmaceutical and finished medical devices, announced today that is has acquired Oval Medical Technologies Ltd., a specialty pharmaceutical device company...
View ArticleClik here to view.
Novocure touts positive TTFields data for pancreatic, ovarian cancer
Novocure (NSDQ:NVCR) shares were up 6% after hours yesterday after the company released positive data for its “tumor treating fields” combined with chemotherapy for pancreatic and ovarian cancer. The...
View Article